Trump Signs Orders Aimed At Lowering Drug Costs

U.S. President Donald Trump has signed four new Executive Orders aimed at lowering the cost of prescription drugs for low-income earners. The four orders, recently announced, include directing federally qualified health centers to pass along discounts on insulin and epinephrine to specified low-income Americans; allowing State plans for safe importation of certain drugs, rather than buying primarily from the U.S. where prices tend to be higher; prohibiting secret deals between drug manufacturers and pharmacy middlemen, to ensure patients directly benefit from discounts at the pharmacy counter; and lastly, ensuring that the United States pays the lowest price available for certain drugs.

As part of efforts to lower drug costs, Trump previously signed a legislation that ended gag clauses which prevented pharmacists from making patients informed about the best prices for the medications they need. The Trump Administration has also notably approved generic drugs at historic rates, approvals that it claims saved patients up to $26 billion in the first 19 months of the President's term.

"Since the day I took office, I have made reducing drug prices one of my highest priorities." Trump said in a press statement.